Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether administration of AZD1656 will affect the
pharmacokinetics of Pioglitazone and vice versa in patients with Type 2 Diabetes Mellitus.